ZTE’s “Signal Reach Program” Wins WSIS 2025 Champion Award
GENEVA, July 10, 2025 /PRNewswire/ --Â ZTE Corporation (0763.HK / 000063.SZ), a global…
New Survey Finds Employers Keen on Hiring Business School Graduates as AI Integration Accelerates
GMAC's latest corporate recruiters survey sends promising signal to recent graduates. RESTON,…
XRP News: Vaultro Finance Presale on XRP ledger Skyrockets Past 50%, As Investors Race to Own $VLT Token
SINGAPORE , June 15, 2025 (GLOBE NEWSWIRE) -- Vaultro Finance has just…
Investigational combination of first-in-class bispecific antibodies TALVEY (talquetamab) and TECVAYLI (teclistamab) shows deep and durable responses in heavily pretreated multiple myeloma patients with extramedullary disease
Results from the Phase 2 RedirecTT-1 study demonstrate deep responses with 78.9…